Nilotinib bests imatinib in chronic myeloid leukemiaQuestions about tolerability and cost of treatment need answering before clinical practice should change Study OKs dose boost for estrogen receptor antagonist Statins benefit leukemia patients Clinical trials needed to pinpoint ideal candidates Chemo- trastuzumab combo ups survival Study finds no difference in adjuvant therapy strategies Continuous aromatase inhibitor therapy no better than starting with tamoxifen Adjuvant therapy has feverish results in real-world care Febrile neutropenia observed at higher than expected rate Groups collaborate on chronic disease prevention $15.5M invested in chronic disease prevention by Canadian Partnership Against Cancer Nova Scotia, Newfoundland form breast cancer screening partnership Surviving cancer poses heart disease risk Hospital report cards may save lives Ont. study gets a negative slant in JAMA, but lead researcher is upbeat about results First Previous 78 79 80 81 82 Next Last
